Plant Comparison
Ginko vs Lions mane
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Ginko and Lions mane: they share 5 indicated uses (arthritis / joint pain, cognitive function, inflammation (general), …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Ginko | Lions mane | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 5/10 | Stronger for Lions mane |
| Cognitive function | 6/10 | 7/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 5/10 | Stronger for Lions mane |
| Memory | 6/10 | 7/10 | Comparable evidence |
| Skin irritation | 1/10 | 5/10 | Stronger for Lions mane |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Antioxidant flavonoids of the leaf, standardised in clinical extracts.
Unique diterpene and sesquiterpene lactones responsible for platelet-activating-factor antagonism and much of the neuroprotective and circulatory activity; also the basis of the bleeding-risk caution.
A neurotoxic compound present in the raw seed; the reason only cooked seed in small amounts, or standardised leaf extract, is used medicinally.
Diterpenoid erinacines (concentrated in the mycelium) and aromatic hericenones (in the fruiting body) are the signature low-molecular-weight compounds that stimulate nerve growth factor synthesis and underlie the mushroom's neurotrophic and neuroprotective effects.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from neuroprotective action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from anticancer action
inferred from neuroprotective action
inferred from immunomodulator action
inferred from digestive action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Generally well tolerated at standard doses but notable interactions exist. Ginkgo has antiplatelet and anticoagulant effects and should not be combined with warfarin, aspirin, or other blood-thinning medications without medical supervision. May lower the seizure threshold — avoid in epilepsy. Possible side effects include headache, dizziness, and GI upset. The raw seeds contain ginkgotoxin and are toxic; only processed leaf extracts are used medicinally.
Duke (2002) rates ginkgo as + (downgraded from higher rating for safety concerns) while noting clinical evidence (score 2) for anti-aggregant (platelet-inhibitory), anti-Alzheimer, and antioxidant activities. Commission E approves ginkgo leaf extract for cognitive deficits, peripheral circulatory disorders, and vertigo. However, Duke emphasizes significant safety concerns: ginkgo substantially increases bleeding risk when combined with anticoagulants (warfarin, aspirin, NSAIDs) and may cause spontaneous bleeding at high doses alone. Dose: 120–240 mg standardized extract (EGb 761) daily. Contraindicated with anticoagulants without medical supervision (Duke, 2002).
Mild gastrointestinal upset (nausea, bloating, diarrhoea) is the most common side effect. Rare allergic reactions can occur, particularly in individuals sensitive to mushrooms, and it may slightly lower blood sugar or have mild blood-thinning effects, so caution is advised for people on diabetes or anticoagulant medications.
External Ids
Botanical Description
Ancient deciduous tree, a 'living fossil' with no close living relatives, bearing distinctive fan-shaped leaves with parallel forking veins that turn brilliant gold in autumn. The tree is dioecious (separate male and female trees); female trees bear fleshy, foul-smelling seed coats surrounding an edible inner nut (ginkgo nut) once the outer flesh is removed.[2]
Wood-decay fungus (not a true plant) forming a distinctive rounded, cushion-like fruiting body covered in long, dangling, tooth-like spines rather than gills or pores, resembling a white or cream 'lion's mane' or icicle cluster. It grows as a single mass rather than a typical cap-and-stem mushroom, on wounds or dead wood of hardwood trees.
Habitat
Native to China, where a small number of wild populations survive; now cultivated worldwide as a resilient, pollution-tolerant ornamental and medicinal tree.
Grows on wounds, dead or dying wood of hardwood trees (notably oak and beech) in temperate forests of the Northern Hemisphere; also widely cultivated commercially on hardwood logs or sawdust substrate.
Harvesting
Leaves are picked in late summer to autumn, when flavonoid and terpenoid content is highest, and processed into standardised extracts; the inner seed is collected in autumn from fallen fruit, with the malodorous outer flesh removed (handled with gloves, as it can irritate skin).
Wild fruiting bodies are collected once mature; cultivated material is harvested from logs or substrate at maturity, then used fresh, dried, or processed into mycelium-based supplements.
Traditional Uses
Ginkgo leaf and seed have a long East Asian tradition: the seed used in traditional Chinese medicine (in small, cooked amounts) for respiratory complaints, and the leaf, though a more recent addition to Western herbalism, now one of the most extensively studied botanicals for cognitive and peripheral circulatory support, reflecting decades of standardised-extract clinical research.[2]
Lion's mane has a long East Asian culinary and medicinal tradition, valued in Chinese and Japanese medicine as a digestive tonic and, more recently, intensively studied for its unique ability to stimulate nerve growth factor, giving it a modern reputation as a neurotrophic and cognitive-support mushroom.[1]
Preparations
Fruiting-body or mycelium extract standardised to erinacine or hericenone content, taken as capsules or powder; the form used in most clinical cognitive-support studies.
Dosage
Clinical trials for cognitive and circulatory support commonly use around 120-240 mg of standardised leaf extract daily, in divided doses. Educational reference only, not a prescription.
A 49-week double-blind randomised trial in mild Alzheimer's disease used three erinacine A-enriched H. erinaceus mycelia capsules per day at 350 mg per capsule, i.e. 1050 mg daily. Other clinical studies of cognitive support commonly use around 1-3 g of dried fruiting body extract daily. Educational reference only, not a prescription.
References
Drug Class Interactions
Not documented
Pairings
Ginkgo and garlic both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[16, 19]
Ginkgo and ginger both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[19, 20]
Ginkgo and feverfew both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[19, 21]
Ginkgo and ginseng both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[19]
Not documented
Lookalikes Review
References & Sources
- Tan, M.S., Yu, J.T., Tan, C.C., Wang, H.F. et al (2015) 'Efficacy and adverse effects of Ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis', Journal of Alzheimer's Disease, 43(2), pp. 589-603. doi:10.3233/JAD-140837 Meta-analysis / review
https://doi.org/10.3233/JAD-140837 - Singh, S.K., Srivastav, S., Castellani, R.J., Plascencia-Villa, G. and Perry, G (2019) 'Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders', Neurotherapeutics, 16(3), pp. 666-674. doi:10.1007/s13311-019-00767-8 Traditional / reference
https://doi.org/10.1007/s13311-019-00767-8 - Diamond, B.J. and Bailey, M.R (2013) 'Ginkgo biloba: indications, mechanisms, and safety', Psychiatric Clinics of North America, 36(1), pp. 73-83. doi:10.1016/j.psc.2012.12.006 Traditional / reference
https://doi.org/10.1016/j.psc.2012.12.006 - DeKosky, S.T., Williamson, J.D., Fitzpatrick, A.L. et al (2008) 'Ginkgo biloba for prevention of dementia: a randomized controlled trial', 300(19), pp. 2253--2262. doi:10.1001/jama.2008.683 Randomized trial
https://doi.org/10.1001/jama.2008.683 - Zhu, C., Liu, J., Lin, J., Xu, J. and Yu, E (2024) 'Investigating the effects of Ginkgo biloba leaf extract on cognitive function in Alzheimer's disease', CNS Neuroscience & Therapeutics, 30(9), pp. e14914. doi:10.1111/cns.14914 Preclinical
https://doi.org/10.1111/cns.14914 - Diamond, B.J., Shiflett, S.C., Feiwel, N., Matheis, R.J., Noskin, O., Richards, J.A. and Schoenberger, N.E (2000) 'Ginkgo biloba extract: mechanisms and clinical indications', Archives of Physical Medicine and Rehabilitation, 81(5), pp. 668-678. doi:10.1016/s0003-9993(00)90052-2 Meta-analysis / review
https://doi.org/10.1016/s0003-9993(00)90052-2 - Dubey, A.K., Shankar, P.R., Upadhyaya, D. and Deshpande, V.Y (2004) 'Ginkgo biloba--an appraisal', Kathmandu University Medical Journal, 2(3), pp. 225-229. Meta-analysis / review
https://scholar.google.com/scholar?q=Ginkgo%20biloba--an%20appraisal - Christen, Y (2004) 'Ginkgo biloba and neurodegenerative disorders', Frontiers in Bioscience, 9, pp. 3091-3104. doi:10.2741/1462 Meta-analysis / review
https://doi.org/10.2741/1462 - Sereda, M., Xia, J., Scutt, P., Hilton, M.P., El Refaie, A. and Hoare, D.J (2022) 'Ginkgo biloba for tinnitus', Cochrane Database of Systematic Reviews, 11, pp. CD013514. doi:10.1002/14651858.CD013514.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD013514.pub2 - DeFeudis, F.V. and Drieu, K (2000) 'Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications', Current Drug Targets, 1(1), pp. 25-58. doi:10.2174/1389450003349380 Meta-analysis / review
https://doi.org/10.2174/1389450003349380 - Xie, L., Zhu, Q. and Lu, J (2022) 'Can we use Ginkgo biloba extract to treat Alzheimer's disease? Lessons from preclinical and clinical studies', Cells, 11(3), pp. 479. doi:10.3390/cells11030479 Meta-analysis / review
https://doi.org/10.3390/cells11030479 - von Gunten, A., Schlaefke, S. and Uberla, K (2015) 'Efficacy of Ginkgo biloba extract EGb 761 in dementia with behavioural and psychological symptoms: a systematic review', World Journal of Biological Psychiatry, 17(8), pp. 622-633. doi:10.3109/15622975.2015.1066513 Meta-analysis / review
https://doi.org/10.3109/15622975.2015.1066513 - World Health Organization (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Kanowski, S., Herrmann, W.M., Stephan, K., Wierich, W. and Hörr, R (1996) 'Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia', 29(2), pp. 47--56. doi:10.1016/s0944-7113(97)80021-9 Randomized trial
https://doi.org/10.1016/s0944-7113(97)80021-9 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Izzo, A.A. and Ernst, E (2009) 'Interactions between herbal medicines and prescribed drugs: an updated systematic review', Drugs, 69(13), pp. 1777-1798. doi:10.2165/11317010-000000000-00000 Meta-analysis / review
https://doi.org/10.2165/11317010-000000000-00000 - Bent, S., Goldberg, H., Padula, A. and Avins, A.L (2005) 'Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature', Journal of General Internal Medicine, 20(7), pp. 657-661. doi:10.1111/j.1525-1497.2005.0121.x Meta-analysis / review
https://doi.org/10.1111/j.1525-1497.2005.0121.x - Diamond, B.J. and Bailey, M.R (2013) 'Ginkgo biloba: indications, mechanisms, and safety', Psychiatric Clinics of North America, 36(1), pp. 73-83. doi:10.1016/j.psc.2012.12.006 Meta-analysis / review
https://doi.org/10.1016/j.psc.2012.12.006 - Ang-Lee, M.K., Moss, J. and Yuan, C.S (2001) 'Herbal medicines and perioperative care', JAMA, 286(2), pp. 208-216. doi:10.1001/jama.286.2.208 Meta-analysis / review
https://doi.org/10.1001/jama.286.2.208 - Jiang, X., Williams, K.M., Liauw, W.S., Ammit, A.J., Roufogalis, B.D., Duke, C.C., Day, R.O. and McLachlan, A.J (2005) 'Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects', British Journal of Clinical Pharmacology, 59(4), pp. 425-432. doi:10.1111/j.1365-2125.2005.02322.x Randomized trial
https://doi.org/10.1111/j.1365-2125.2005.02322.x - Groenewegen, W.A. and Heptinstall, S (1990) 'A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro', Journal of Pharmacy and Pharmacology, 42(8), pp. 553-557. doi:10.1111/j.2042-7158.1990.tb07057.x Preclinical
https://doi.org/10.1111/j.2042-7158.1990.tb07057.x
- Szucko-Kociuba, I., Trzeciak-Ryczek, A., Kupnicka, P. and Chlubek, D (2023) 'Neurotrophic and Neuroprotective Effects of Hericium erinaceus', International Journal of Molecular Sciences, 24(21). doi:10.3390/ijms242115960 Preclinical
https://doi.org/10.3390/ijms242115960 - Contato, A.G. and Conte-Junior, C.A (2025) 'Lion's Mane Mushroom (Hericium erinaceus): A Neuroprotective Fungus with Antioxidant, Anti-Inflammatory, and Antimicrobial Potential - A Narrative Review', Nutrients, 17(8), pp. 1307. doi:10.3390/nu17081307 Meta-analysis / review
https://doi.org/10.3390/nu17081307 - Li, I.C. and Chang, H.H. and Lin, C.H. and Chen, W.P. and Lu, T.H. and Lee, L.Y. and Chen, Y.W. and Chen, Y.P. and Chen, C.C. and Lin, D.P (2020) 'Prevention of Early Alzheimer's Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study', Frontiers in Aging Neuroscience, 12, pp. 155. doi:10.3389/fnagi.2020.00155 Clinical study
https://doi.org/10.3389/fnagi.2020.00155 - Friedman, M (2015) 'Chemistry, Nutrition, and Health-Promoting Properties of Hericium erinaceus (Lion's Mane) Mushroom Fruiting Bodies and Mycelia and Their Bioactive Compounds', Journal of Agricultural and Food Chemistry, 63(32), pp. 7108-7123. doi:10.1021/acs.jafc.5b02914 Meta-analysis / review
https://doi.org/10.1021/acs.jafc.5b02914 - Xie, G. and Tang, L. and Xie, Y. and Xie, L (2022) 'Secondary Metabolites from Hericium erinaceus and Their Anti-Inflammatory Activities', Molecules, 27(7), pp. 2157. doi:10.3390/molecules27072157 Preclinical
https://doi.org/10.3390/molecules27072157 - Li, H., Feng, J., Liu, C., Hou, S., Meng, J., Liu, J.Y. and others (2024) 'Polysaccharides from an edible mushroom, Hericium erinaceus, alleviate ulcerative colitis in mice by inhibiting the NLRP3 inflammasomes and reestablish intestinal homeostasis', International Journal of Biological Macromolecules. doi:10.1016/j.ijbiomac.2024.131251 Preclinical
https://doi.org/10.1016/j.ijbiomac.2024.131251 - Shi, X.Z., Zhang, X.Y., Wang, Y.Y., Zhao, Y.M. and Wang, J (2024) 'Polysaccharides from Hericium erinaceus and its immunomodulatory effects on RAW 264.7 macrophages', International Journal of Biological Macromolecules. doi:10.1016/j.ijbiomac.2024.134947 Preclinical
https://doi.org/10.1016/j.ijbiomac.2024.134947 - Liu, J.H., Li, L., Shang, X.D., Zhang, J.L. and Tan, Q (2016) 'An experimental research on the anti-gastric-cancer activity of hericenone B extracted from Hericium erinaceus', 37(1), pp. 1--8. Traditional / reference
https://scholar.google.com/scholar?q=An%20experimental%20research%20on%20the%20anti-gastric-cancer%20activity%20of%20hericenone%20B%20extracted%20from%20Hericium%20erinaceus - Mori, K., Inatomi, S., Ouchi, K., Azumi, Y. and Tuchida, T (2009) 'Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial', 23(3), pp. 367--372. doi:10.1002/ptr.2634 Randomized trial
https://doi.org/10.1002/ptr.2634 - National Institutes of Health (2023) 'Hericium erinaceus'. Available at: https://pubmed.ncbi.nlm.nih.gov/?term=hericium+erinaceus Traditional / reference
https://pubmed.ncbi.nlm.nih.gov/?term=hericium+erinaceus - Pellegrino, R. and Gravina, A.G (2025) 'Potential of traditional Chinese medicine in gastrointestinal disorders: Hericium erinaceus in chronic atrophic gastritis', World Journal of Gastroenterology, 31(20). doi:10.3748/wjg.v31.i20.106615 Traditional / reference
https://doi.org/10.3748/wjg.v31.i20.106615 - Docherty, S., Doughty, F.L. and Smith, E.F (2023) 'The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study', Nutrients, 15(22). doi:10.3390/nu15224842 Randomized trial
https://doi.org/10.3390/nu15224842 - Surendran, G., Saye, J., Binti Mohd Jalil, S., Spreadborough, J., Duong, K., Shatwan, I.M. and others (2025) 'Acute effects of a standardised extract of Hericium erinaceus (Lion's Mane mushroom) on cognition and mood in healthy younger adults: a double-blind randomised placebo-controlled study', Frontiers in Nutrition. doi:10.3389/fnut.2025.1405796 Randomized trial
https://doi.org/10.3389/fnut.2025.1405796 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.